SLC5A2 and stroke disorder: Similarly, elderly patients, apparently those with the lowest indication to use SGLT2 inhibitors, have taken advantage from the best prognosis, even though it will be important to better define the relationship between increased blood cells count and the small, not significant signal of risk of stroke.